452 filings
Page 5 of 23
D
rypj0x9r
27 Sep 22
$12.84M in options / securities to be acquired, sold $12.84M, 21 investors
4:16pm
424B5
y1iai7roa
14 Sep 22
Prospectus supplement for primary offering
12:19pm
6-K
v4x ie0js
14 Sep 22
Akari Therapeutics Announces $12.75 Million Registered Direct Offering
12:02pm
6-K
hp4yc4cm3q
1 Aug 22
Current report (foreign)
5:00pm
6-K
86vdat8ao6xsi
29 Jul 22
Current report (foreign)
5:00pm
6-K
wwe88lz4
20 Jul 22
Current report (foreign)
4:42pm
6-K
8n4d0gy0wyid8i
7 Jul 22
Current report (foreign)
7:21pm
6-K
c9wqmuirq8so3tb
5 Jul 22
Current report (foreign)
5:21pm
6-K
st0xd3
15 Jun 22
Current report (foreign)
7:40pm
6-K
c5cgnhn73 inmvp
6 Jun 22
This Document Is Important and Requires Your Immediate Attention
6:41pm
6-K
18iyqvoyn9bb 2flb
20 May 22
Akari Therapeutics Presents Results from the CASCADE and CORONET Studies in COVID-19 at the American Thoracic Society (ATS) 2022 Annual Meeting
4:30pm
6-K
gg261w
17 May 22
Akari Therapeutics Reports Full Year 2021 Financial Results and Highlights Clinical Progress
4:30pm
6-K
4mwi5
11 May 22
Current report (foreign)
8:52am
6-K
rl6l34
9 May 22
Current report (foreign)
4:52pm
NT 20-F
s36u 9w9dbm4x
29 Apr 22
Notice of late annual filing (foreign)
12:00am
424B5
wrhttfzicayb9
9 Mar 22
Prospectus supplement for primary offering
9:39pm
6-K
dyh12c
9 Mar 22
Akari Therapeutics, Plc Announces $9.0 Million Registered Direct Offering
9:35pm
6-K
u39avlvywd3qu akhs
4 Mar 22
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
4:58pm
6-K
lst hs7js12czxpf9cbh
28 Feb 22
Current report (foreign)
5:15pm